Welcome : Guest

Aviragen Therapeutics, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Aviragen Therapeutics, Inc., which is principally involved in the Discovery and Development of Direct-Acting Antivirals to Treat Infections. Illustrated with 14 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-65950
Price: $700
Company Type: Public
Pages: 18
Date: January 2017
Market Data Tables: 14

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Aviragen Therapeutics, Inc.'s (Formerly Biota Pharmaceuticals Inc.) Sales by Product Segment (2015) in Percentage for Relenza®, Inavir®, and Revenue from Services......3
Gram Infections......6
Table 2: Gram Infection Market by Segment in European Union (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......6
Table 3: Gram Infection Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Other......7
Infectious Disease Drugs......8
Table 4: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......8
Table 5: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......9
Antibiotics......10
Table 6: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......10
Table 7: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......11
Respiratory......12
Table 8: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......12
Table 9: Respiratory Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Allegra and Telfast, Claritin and Clarinex, Flixotide and Flovent, Seretide and Advair, Spiriva, Symbicort, Xolair, and Others......13
Respiratory Virus Tests......14
Table 10: Respiratory Virus Tests Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for United States, and Others......14
Respiratory Therapeutics......15
Table 11: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......15
Anti-Infectives......16
Table 12: Market Shares of Leading Anti-Infective Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Bayer AG, Merck & Co., Inc., Vétoquinol S.A., Virbac S.A., Zoetis, Inc. and Other......16
Infectious Disease Drugs......17
Table 13: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......17
Respiratory Therapeutics......18
Table 14: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......18